Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.
Hansen PB et al. Support Care Cancer. 2016 Dec 13. [Epub ahead of print].
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M et al. Cochrane Database Syst Rev. 2016 Dec 1;12:CD008500. [Epub ahead of print].